CoronaryAtlas logo
CoronaryAtlas
Monocyte Chemoattractant Protein-1
Pathway / Plaque inflammation

Monocyte Chemoattractant Protein-1

CCL2protein

MCP-1 recruits monocytes to the atherosclerotic plaque and inflamed endothelium, sustaining plaque destabilization.

Pathway placement
Cascade stepPlaque inflammation
Confidencehigh
RationaleChemokine driving monocyte/macrophage recruitment in atherosclerotic inflammation and ACS.
Also acts inPlatelet activation
Druggability
DruggableYes
Known drugs / candidates1
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000108691

Type I vs Type II discrimination

ScoresShared / rises in both
R — rupture / Type-I
67
C — confounder / Type-II
58
A — assay feasibility
72
E — evidence strength
52
T1DI (composite)
20
Specificity differential (R−C)+8.3
Confounder panel (Type-II drivers)
1sepsis / systemic inflammationmag 2
2anemia / acute blood lossn/a
3hypovolemia / dehydrationmag 2
4tachyarrhythmiamag 2
5hypoxemia / respiratory failuren/a
6hypertensive emergencyn/a
7high-demand / peri-operative stressmag 1
Coverage: 4/7 confounders with evidence
Tier: deep-scored (abstract-extracted) · 18 supporting references. See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)

Literature evidence(24)